We are pleased to announce that the UWM Chemistry & Biochemistry Department has selected ten UWM graduate students for the 2025 Sterling Pharma Conference Travel Awards using funds provided to us by Sterling Pharma Solutions. Sterling Pharma Solutions is a …
We are proud to announce that after several years of unsuccessful grant applications, we finally received funds to establish a new and equitable pathway for high school graduates and students who discontinued a STEM program to enter the local STEM …
The MIDD just recently started to collaborate with Simmpyra Pharmaceuticals, a new startup company that is located at the new UWM chemistry building. CEO and cofounder Gunnar Gottschalk and CSO and co-founder Avik Roy are focusing on the development of …
The MIDD has started to work with Sanacor, Inc last summer and is planning to support Sanacor during their journey to develop new therapies to alleviate mitochondrial dysfunction in cardiometabolic diseases. Sanacor co-founder Mike Widlansky and MIDD director Leggy Arnold …
We are delighted to announce that Sterling Pharma Solutions is supporting the UWM Chemistry & Biochemistry Department and the MIDD. The new UWM chemistry building has dedicated spaces for a variety of educational chemistry programs for undergraduate and graduate students. …
The inaugural Wisconsin WISER conference took place at the Medical College of Wisconsin and was attended by nearly 500 scientists including undergraduate and graduate students from local educational institutions. The conference was a great success supported by an exceptional organizing …
The MIDD has been collaborating with Glen Hills Middle School teacher Lalitha Murali and her students supported by the iEDU program Cubes in Space. This program is for non-university students to conduct suborbital scientific and engineering research. The purpose of …
Nearly 1/3 of Americans will experience an anxiety disorder in their lifetime resulting in impaired social function and reduction of quality of life. Unfortunately, existing anxiety medications suffer from delayed or inadequate efficacy and sedative-hypnotic effects. Development of additional anxiolytics …
Glioblastoma (GBM) is an extremely aggressive cancer for which there are limited treatment options. Despite recent advances in therapy, the prognosis remains dismal and patient survival is short. After standard therapy, the recurrent tumors become resistant to therapy and render …
The effects of space travel on the human body, particularly on the skeletal system, are a critical area of research especially considering NASA’s goals to send humans to the moon again and to Mars (Artemis Accords). As astronauts venture beyond …